Research
Hormonal
Dietary fiber intake modulates gastrointestinal transit time, which serves as a key mechanism for improving glucose homeostasis and reducing the risk of metabolic diseases like obesity and type 2 diabetes.
Increase your intake of dietary fibers from various plant sources (whole grains, vegetables, legumes) to support healthy gastrointestinal transit. This can help regulate blood sugar levels and may reduce the risk of metabolic diseases. Start gradually to minimize digestive discomfort.
ModerateSupportsMEDIUM confidence
Modulation of gastrointestinal transit may be one of the mechanisms underlying the beneficial health effects of dietary fibers. These effects include improved glucose homeostasis and a reduced risk of developing metabolic diseases such as obesity and type 2 diabetes mellitus.
Why this rating
The paper is a review summarizing observational and intervention studies, noting inconsistencies in human data.
Source
Gastrointestinal Transit Time, Glucose Homeostasis and Metabolic Health: Modulation by Dietary Fibers
Mattea Müller et al. · Nutrients · 2018
DOI 10.3390/nu10030275
narrative_reviewCited 321×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Viscous soluble fibers (e.g., beta-glucans, pectin, psyllium) delay gastric emptying, which contributes to reduced postprandial glucose concentrations and improved insulin sensitivity.Moderate
- Accelerated gastric emptying in overweight and obese individuals may contribute to rapid postprandial glucose increases and insulin resistance.Limited
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →